Prudential Financial
OMED

Prudential Financial’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Prudential Financial’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-89,811
Closed -$1.49M – 2332
2015
Q3 		$1.49M Buy
+89,811
New +$1.8M ﹤0.01% 1592

Other funds holding OMED

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Prudential Financial's OMED Position: Q4 2015 in Review

Prudential Financial sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q4 2015, closing a stake of 89,811 shares — an estimated $1.49M sold.

Prudential Financial first reported a position in OMED in Q3 2015 and held it in 1 quarter. The position peaked at $1.49M in Q3 2015. 83 funds tracked by Wall St. Rank hold OMED as of Q4 2015.

  • Prudential Financial reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Prudential Financial sold 89,811 OncoMed Pharmaceuticals, Inc. shares in Q4 2015, an estimated $1.49M.
  • Prudential Financial first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Prudential Financial's OncoMed Pharmaceuticals, Inc. position peaked at $1.49M in Q3 2015.
  • 83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2015.

Based on Prudential Financial's 13F filing for Q4 2015, filed 12 Feb 2016.